Joseph Haas
Senior writer
Senior writer
Maryland, USA
+13 year(s) experience
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
The companies are combining their technologies to seek neutralizing antibody therapeutics that could prevent or treat COVID-19, building on their previous partnership in monitoring minimal residual disease in blood cancers.
Topic Coronavirus
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
The companies are combining their technologies to seek neutralizing antibody therapeutics that could prevent or treat COVID-19, building on their previous partnership in monitoring minimal residual disease in blood cancers.
Topic Coronavirus
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Biktarvy’s powerful sales growth and the potential of a first-in-class capsid inhibitor in both prevention and heavily treatment-experienced patients are key to Gilead’s plan for staying on top in HIV.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
The Medicines Co. unveiled Phase III safety data for inclisiran showing safety and tolerability comparable to placebo and efficacy in line with the PCSK9 inhibitor class – which should be the reassurance it needs for the oral agent.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Looking back at the second quarter, PharmaVitae analysts have selected 10 biopharma companies with market caps under $3bn they think are primed for acquisition – and the likely candidates for a buy-out.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
ODYSSEY Outcomes data added to US label for Praluent; update includes claim for reduced cardiovascular incident risk and trial data indicating an all-cause mortality benefit.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Gilead took a risky approach with selonsertib in NASH, pursuing a tough liver fibrosis benefit and failing, continuing a trend of disappointments outside of its antiviral franchises. Analysts don’t expect the second Phase III study in less-sick patients to succeed either.
Topic Drug review Drug approval Drug development landscape Clinical trials
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Offering better efficacy than Shire’s existing HAE therapies and dosing convenience compared to CSL Behring’s prophylactic Haegarda, the specialty pharma may take back market share lost to its competitor and consolidate its leadership in the space.
Topic fda
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
The pharma and the Google spinout focused on aging are adding $1bn in funding to their 2014 collaboration, which has yielded more than two dozen preclinical candidates so far.
Topic alzheimers
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Having previously criticized the biopharma industry for squandering the benefits of US tax reform, the former Teva CEO called for more M&A deals that offer a clear strategic rationale, pointing to Takeda/Shire as an example.
Topic biopharmaceutical
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Longitudinal observational study of NASH patients provides data to companies to help them better understand disease.
Topic Clinical trials
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
While Mustang was acquiring CAR-T intellectual property from Harvard and Juno licensed gamma-secretase inhibitor.
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Following its partnership with Dicerna, the German pharma signs a second NASH deal with MiNA and inks three cancer-related transactions, including divestitures. Also, Amgen buys out Kirin’s half of their joint venture for $780m.
Topic business-strategies
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Within weeks of its acquisition of Kite, Gilead is working to launch its first immuno-oncology drug, with a goal of training.
Topic immuno-oncology
Scrip: 世界の医療用医薬品＆製薬産業に関するニュース
Phase III APOLLO results finally give the beleagured firm the first late-stage success
Topic clinical-trials
Scrip: 世界の医療用医薬品＆製薬産...
27 Oct 2020
Scrip: 世界の医療用医薬品＆製薬産...
23 Oct 2020
Scrip: 世界の医療用医薬品＆製薬産...
16 Oct 2020
Pink Sheet: 世界の薬事規制と...
14 Oct 2020
Scrip: 世界の医療用医薬品＆製薬産...
14 Oct 2020
Scrip: 世界の医療用医薬品＆製薬産...
30 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
28 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
24 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
21 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
19 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
14 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
04 Sep 2020
Scrip: 世界の医療用医薬品＆製薬産...
21 Aug 2020
Scrip: 世界の医療用医薬品＆製薬産...
11 Aug 2020
Scrip: 世界の医療用医薬品＆製薬産...
10 Aug 2020